Tag:
Bioheart
Latest Headlines
Latest Headlines
Groth resigns as Bioheart CEO
Karl Groth resigned as chairman and director of Bioheart, and has been replaced by William Murphy, Jr., according to a filing with the Securities and Exchange Commission. It gave no reason for his
BioHeart stem cell treatment achieves positive response
Bioheart (BHRT) shares are up 22 percent today on the news that a Phase II/III clinical trial of its stem cell treatment for heart failure is producing promising results. The treatment is among the
Bioheart alerts SEC of cash crunch
Less than a year after going public and raising close to $6 million, the stem cell company Bioheart has alerted the SEC that it missed a scheduled $180,000 loan payment and is seeking new money to
Researchers testing stem cell therapy for CHF
Researchers in Florida are beginning a small, early-stage human trial to test a new stem cell therapy for congestive heart failure. The physicians are taking premature muscle cells--called
